Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kitae Kim

Showing results (281-290 of 314) with videos related to

Pageof 32
Sort By:
Thrombosis Research|November 10, 2019
Clinical outcomes of patients with pulmonary embolism versus deep vein thrombosis: From the COMMAND VTE RegistryYugo Yamashita, Koichiro Murata, Takeshi Morimoto, et al.
Journal of Thrombosis and Thrombolysis|July 31, 2020
Clinical characteristics and outcomes of patients with venous thromboembolism according to diagnosis on weekends versus on weekdaysYugo Yamashita, Takeshi Morimoto, Hidewo Amano, et al.
Journal of the American Heart Association|October 22, 2024
Incidence of Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism in the Era of Direct Oral Anticoagulants: From the COMMAND VTE Registry-2Nobutaka Ikeda, Yugo Yamashita, Takeshi Morimoto, et al.
Thrombosis and Haemostasis|June 24, 2019
Risk Factors for Major Bleeding during Prolonged Anticoagulation Therapy in Patients with Venous Thromboembolism: From the COMMAND VTE RegistryKitae Kim, Yugo Yamashita, Takeshi Morimoto, et al.
Thrombosis Research|February 28, 2026
Impact of body weight on clinical outcomes in cancer patients with low-risk pulmonary embolism receiving rivaroxaban: Insights from the ONCO PE trialToru Sato, Yoshito Ogihara, Yugo Yamashita, et al.
Circulation|August 28, 2023
Edoxaban for 12 Months Versus 3 Months in Patients With Cancer With Isolated Distal Deep Vein Thrombosis (ONCO DVT Study): An Open-Label, Multicenter, Randomized Clinical TrialYugo Yamashita, Takeshi Morimoto, Nao Muraoka, et al.
Journal of Intensive Care|November 4, 2024
Clinical characteristics and short-term outcomes of patients with critical acute pulmonary embolism requiring extracorporeal membrane oxygenation: from the COMMAND VTE Registry-2Kensuke Takabayashi, Yugo Yamashita, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 28, 2025
Concomitant Antiplatelet Therapy in Patients With Venous Thromboembolism Treated With Anticoagulants　- Insights From the COMMAND VTE Registry-2Kazuhisa Kaneda, Yugo Yamashita, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 22, 2024
Newly Diagnosed Cancer After Diagnosis of Venous Thromboembolism　- Insights From the COMMAND VTE Registry-2Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, et al.
Journal of the American Heart Association|September 30, 2024
Selection of Home Treatment and Identification of Low-Risk Patients With Pulmonary Embolism Based on Simplified Pulmonary Embolism Severity Index Score in the Era of Direct Oral AnticoagulantsRyusuke Nishikawa, Yugo Yamashita, Takeshi Morimoto, et al.
Pageof 32

Showing results (281-290 of 314) with videos related to

Sort By:
Pageof 32
Thrombosis Research|November 10, 2019
Clinical outcomes of patients with pulmonary embolism versus deep vein thrombosis: From the COMMAND VTE RegistryYugo Yamashita, Koichiro Murata, Takeshi Morimoto, et al.
Journal of Thrombosis and Thrombolysis|July 31, 2020
Clinical characteristics and outcomes of patients with venous thromboembolism according to diagnosis on weekends versus on weekdaysYugo Yamashita, Takeshi Morimoto, Hidewo Amano, et al.
Journal of the American Heart Association|October 22, 2024
Incidence of Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism in the Era of Direct Oral Anticoagulants: From the COMMAND VTE Registry-2Nobutaka Ikeda, Yugo Yamashita, Takeshi Morimoto, et al.
Thrombosis and Haemostasis|June 24, 2019
Risk Factors for Major Bleeding during Prolonged Anticoagulation Therapy in Patients with Venous Thromboembolism: From the COMMAND VTE RegistryKitae Kim, Yugo Yamashita, Takeshi Morimoto, et al.
Thrombosis Research|February 28, 2026
Impact of body weight on clinical outcomes in cancer patients with low-risk pulmonary embolism receiving rivaroxaban: Insights from the ONCO PE trialToru Sato, Yoshito Ogihara, Yugo Yamashita, et al.
Circulation|August 28, 2023
Edoxaban for 12 Months Versus 3 Months in Patients With Cancer With Isolated Distal Deep Vein Thrombosis (ONCO DVT Study): An Open-Label, Multicenter, Randomized Clinical TrialYugo Yamashita, Takeshi Morimoto, Nao Muraoka, et al.
Journal of Intensive Care|November 4, 2024
Clinical characteristics and short-term outcomes of patients with critical acute pulmonary embolism requiring extracorporeal membrane oxygenation: from the COMMAND VTE Registry-2Kensuke Takabayashi, Yugo Yamashita, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 28, 2025
Concomitant Antiplatelet Therapy in Patients With Venous Thromboembolism Treated With Anticoagulants　- Insights From the COMMAND VTE Registry-2Kazuhisa Kaneda, Yugo Yamashita, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 22, 2024
Newly Diagnosed Cancer After Diagnosis of Venous Thromboembolism　- Insights From the COMMAND VTE Registry-2Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, et al.
Journal of the American Heart Association|September 30, 2024
Selection of Home Treatment and Identification of Low-Risk Patients With Pulmonary Embolism Based on Simplified Pulmonary Embolism Severity Index Score in the Era of Direct Oral AnticoagulantsRyusuke Nishikawa, Yugo Yamashita, Takeshi Morimoto, et al.
Pageof 32